These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25421045)

  • 1. Use of contemporary genetics in cardiovascular diagnosis.
    George AL
    Circulation; 2014 Nov; 130(22):1971-80. PubMed ID: 25421045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics: the genetics of variable drug responses.
    Roden DM; Wilke RA; Kroemer HK; Stein CM
    Circulation; 2011 Apr; 123(15):1661-70. PubMed ID: 21502584
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetics and cardiovascular disease: a policy statement from the American Heart Association.
    Ashley EA; Hershberger RE; Caleshu C; Ellinor PT; Garcia JG; Herrington DM; Ho CY; Johnson JA; Kittner SJ; Macrae CA; Mudd-Martin G; Rader DJ; Roden DM; Scholes D; Sellke FW; Towbin JA; Van Eyk J; Worrall BB;
    Circulation; 2012 Jul; 126(1):142-57. PubMed ID: 22645291
    [No Abstract]   [Full Text] [Related]  

  • 4. From SNPs to functional studies in cardiovascular pharmacogenomics.
    Cresci S
    Methods Mol Biol; 2008; 448():379-93. PubMed ID: 18370238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments.
    Berinstein E; Levy A
    Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):973-983. PubMed ID: 28792790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics and pharmacogenetics in the diagnosis and therapy of cardiovascular diseases.
    Krasi G; Precone V; Paolacci S; Stuppia L; Nodari S; Romeo F; Perrone M; Bushati V; Dautaj A; Bertelli M
    Acta Biomed; 2019 Sep; 90(10-S):7-19. PubMed ID: 31577248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases].
    Dzida G
    Kardiol Pol; 2004 Mar; 60(3):304-8. PubMed ID: 15156230
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacogenomics of cardiovascular pharmacology].
    Tanaka T; Oka T; Iwao H
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):130-2. PubMed ID: 16971774
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.
    Mango R; Vecchione L; Raso B; Borgiani P; Brunetti E; Mehta JL; Lauro R; Romeo F; Novelli G
    Expert Opin Pharmacother; 2005 Dec; 6(15):2565-76. PubMed ID: 16316297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine.
    Nakagawa K; Ishizaki T
    Pharmacol Ther; 2000 Apr; 86(1):1-28. PubMed ID: 10760544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects of personalized medicine in cardiovascular diseases.
    Lenfant C
    Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.
    Zaiou M; Benachour H; Marteau JB; Visvikis-Siest S; Siest G
    Curr Pharm Des; 2009; 15(27):3193-206. PubMed ID: 19754391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision Cardiovascular Medicine: State of Genetic Testing.
    Giudicessi JR; Kullo IJ; Ackerman MJ
    Mayo Clin Proc; 2017 Apr; 92(4):642-662. PubMed ID: 28385198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implementation of Cardiovascular Pharmacogenomics.
    Pereira NL; Stewart AK
    Mayo Clin Proc; 2015 Jun; 90(6):701-4. PubMed ID: 26046404
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics.
    Johnson JA
    Circulation; 2008 Sep; 118(13):1383-93. PubMed ID: 18809808
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular pharmacogenetics.
    Myburgh R; Hochfeld WE; Dodgen TM; Ker J; Pepper MS
    Pharmacol Ther; 2012 Mar; 133(3):280-90. PubMed ID: 22123178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics to Revive Drug Development in Cardiovascular Disease.
    Dubé MP; de Denus S; Tardif JC
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):59-64. PubMed ID: 26768480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular pharmacogenomics and individualized drug therapy.
    Pereira NL; Weinshilboum RM
    Nat Rev Cardiol; 2009 Oct; 6(10):632-8. PubMed ID: 19707183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics and cardiology: improving treatment with existing drugs.
    Sorrentino MJ; O'Donnell PH
    Pharmacogenomics; 2015; 16(11):1223-6. PubMed ID: 26369612
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic Testing in Cardiovascular Medicine.
    Marian AJ
    Tex Heart Inst J; 2018 Aug; 45(4):231-232. PubMed ID: 30374232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.